Introduction

Category: Opioids (page 2)

Category: Opioids (page 2)

Graphic Description – Medicolegal Death Investigation Frequently Used Data Elements for Toxicology and Seized Drugs

Date February 2024 Overview The National Institute of Justice (NIJ)—in partnership with its Forensic Technology Center of Excellence (FTCOE) at RTI International and the National Center for Health Statistics, Centers for Disease Control and Prevention (CDC)—convened a virtual Medicolegal Death…
Continue reading “Graphic Description – Medicolegal Death Investigation Frequently Used Data Elements for Toxicology and Seized Drugs”…

White Paper – Forensic Community Drug Database Conceptualization

Date February 2024 Overview The National Institute of Justice (NIJ)—in partnership with its Forensic Technology Center of Excellence (FTCOE) at RTI International and the National Center for Health Statistics, Centers for Disease Control and Prevention (CDC)—convened a virtual Medicolegal Death…
Continue reading “White Paper – Forensic Community Drug Database Conceptualization”…

Technical Note – The Use of Neutral Losses and Common Fragments Screening by QTOF in Forensic Laboratories

Date February 2024 Overview Quadrupole time-of-flight (QTOF) mass spectrometry is an advanced analytical technique that has some capabilities that make it particularly useful in screening in toxicology cases for unknown analytes. The technology combines the power of a quadrupole mass…
Continue reading “Technical Note – The Use of Neutral Losses and Common Fragments Screening by QTOF in Forensic Laboratories”…

Drug Surveillance Initiatives: An FTCOE Repository of Resources

Date Last Updated: September 2024 Published: December 2023 Overview In the realm of drug surveillance, a multitude of data sources originate from diverse funding agencies, including but not limited to the Drug Enforcement Administration (DEA), National Institute on Drug Abuse…
Continue reading “Drug Surveillance Initiatives: An FTCOE Repository of Resources”…

White Paper – Information Sharing Between Medicolegal Death Investigators and Toxicology Testing Services

Date December 2023 Overview The National Institute of Justice (NIJ)—in partnership with its Forensic Technology Center of Excellence (FTCOE) at RTI International and the National Center for Health Statistics, Centers for Disease Control and Prevention (CDC)—convened a virtual Medicolegal Death…
Continue reading “White Paper – Information Sharing Between Medicolegal Death Investigators and Toxicology Testing Services”…

Implementation Workshop: TOF/QTOF Mass Spectrometry for Identification, Screening, and Confirmation in Forensic Toxicology and Chemistry

Overview This event originally occurred on October 18, 2023 Duration 5.5 hours This virtual workshop aims to provide guidance to forensic science service providers (FSSPs) involved in the planning, purchase, use, or quality assurance surrounding TOF/QTOF-MS instrumentation. The speakers for…
Continue reading “Implementation Workshop: TOF/QTOF Mass Spectrometry for Identification, Screening, and Confirmation in Forensic Toxicology and Chemistry”…

Investigation & Certification of Drug Toxicity Death Training

Overview Continuing Education Credits Available 3.75 AMA PRA Category 1 Credits™ 0.4 IACET Continuing Education Units 3.75 ABMDI Continuing Education Credits The Centers for Disease Control and Prevention (CDC) engaged the CDC’s federally funded research and development center (FFRDC) –…
Continue reading “Investigation & Certification of Drug Toxicity Death Training”…

The Sentinel Role of Forensic Toxicology Laboratories to Identify and Act Upon Diverse Drug Threats by Addressing Toxicology and Economic Demands

Publication Forensic Science International: Synergy, September, 2022 Authors Jeri D. Ropero Miller | RTI International Lawrance D. Mullen | RTI International Paul J. Speaker | West Virginia University Introduction The societal costs from substance abuse are extensive and include treatment…
Continue reading “The Sentinel Role of Forensic Toxicology Laboratories to Identify and Act Upon Diverse Drug Threats by Addressing Toxicology and Economic Demands”…